Oxidative Medicine and Cellular Longevity
SJR1.643
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.643 | Q1 | 93.2% | |
| 2024 | — | — | 1.673 | Q1 | 93.5% | |
| 2023 | — | — | 1.477 | Q1 | 92.5% | |
| 2022 | — | — | 1.324 | Q1 | 91.4% | |
| 2021 | — | — | 1.233 | Q1 | 90.4% | |
| 2020 | — | — | 1.494 | Q1 | 92.3% | |
| 2019 | — | — | 1.394 | Q1 | 91.6% | |
| 2018 | — | — | 1.388 | Q1 | 90.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1942-0900
ISSN
1942-0994
region
Western Europe
coverage
2008-2026